•  
  •  
  •  
  •  

2025-10-14 14:48:43

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Marquee Middle East Operator Strengthens Fraud Management with Subex
  • Infosys Chosen by NHSBSA to Deliver a New Workforce Management Solution for the NHS in England and Wales
  • Aditya Birla Money Ltd Q2 FY2026 PAT at Rs. 10.14 crores
  • ICICI Prudential Life Insurance Company Ltd Q2FY26 consolidated net profit at Rs. 295.83 crores
  • Aptech Ltd receives order worth Rs. 2.54 crore

Keywords Selected:  SPARC

Stock Report

  • SPARC announces submission of IND Application for SBO-154 to USFDA
  • SPARC Announces Signing of Binding Letter of Intent with UCSF and Tiller Therapeutics for Pre-clinical Oncology Asset and Associated Intellectual Property
  • SPARC announces results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease
  • Sun Pharma Advanced Research Company Ltd Q3 FY24 loss at Rs. 99.65 crores
  • Sun Pharma Advanced Research Company Ltd Q4 FY2022-23 loss at Rs. 81.99 crores
  • Sun Pharma Advanced Research Company Ltd reports profit in Q3FY23
  • SEZABY™ approved by US FDA for the treatment of neonatal seizures
  • Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US
  • Sun Pharma Advanced Research Company Ltd Q2 FY2023 loss at Rs. 68.40 crores
  • Sun Pharma Advanced Research Company Ltd Q1FY23 loss widens to Rs. 82.35 crores
  • Sun Pharma Advanced Research Company Ltd Q4FY22 net loss widens to Rs. 71.05 crores
  • Sun Pharma Advanced Research Company Q3FY22 loss at Rs. 15.84 crores
  • SPARC to present updated clinical data of vodobatinib (SCO-088) at the 63rd ASH annual meeting
  • SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma
  • SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target
  • Sun Pharma Advanced Research Company Ltd posts loss of Rs. 55.14 crore in Q2 FY22

Latest Post

  • Marquee Middle East Operator Strengthens Fraud Management with Subex
  • Infosys Chosen by NHSBSA to Deliver a New Workforce Management Solution for the NHS in England and Wales
  • Aditya Birla Money Ltd Q2 FY2026 PAT at Rs. 10.14 crores
  • ICICI Prudential Life Insurance Company Ltd Q2FY26 consolidated net profit at Rs. 295.83 crores
  • Aptech Ltd receives order worth Rs. 2.54 crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024